Clinical Trial Update: A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

View source ↗

Summary

Pfizer-sponsored clinical trial evaluating novel hormonal therapies for metastatic castration-sensitive prostate cancer has completed, with results posted in la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Pfizer | Conditions: Prostatic Neoplasms | Status: COMPLETED | Results posted: 2025-12-31